Zobrazeno 1 - 10
of 622
pro vyhledávání: '"Afrough B"'
Autor:
Adam MAM; Department of Genomics, National Public Health Laboratory (NPHL), Khartoum, Sudan., Sims S; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Awad AA; Department of Bacteriology, National Public Health Laboratory (NPHL), Khartoum, Sudan., Meredith L; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt., Mohamed Ahmed BAE; Department of Genomics, National Public Health Laboratory (NPHL), Khartoum, Sudan., Ahmed RAA; Department of Genomics, National Public Health Laboratory (NPHL), Khartoum, Sudan., Saeed HAI; National Influenza Center (NIC), National Public Health Laboratory (NPHL), Khartoum, Sudan., Alkhidir MA; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt., Abdelgadir MIA; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt., Mohamed HA; Department of Molecular Biology, National Public Health Laboratory (NPHL), Khartoum, Sudan., Badi LA; National Influenza Center (NIC), National Public Health Laboratory (NPHL), Khartoum, Sudan., Vazquez YG; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Afrough B; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Inamdar L; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Kritz A; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Barakat A; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt., Abualas E; Department of Bacteriology, National Public Health Laboratory (NPHL), Khartoum, Sudan., Bedri SA; Sudan National Public Health Laboratory (NPHL), Khartoum, Sudan.
Publikováno v:
Microbiology resource announcements [Microbiol Resour Announc] 2024 Oct 09, pp. e0037624. Date of Electronic Publication: 2024 Oct 09.
Autor:
de Abreu Góes Pereira VM; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Gularte JS; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Demoliner M; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., da Silva MS; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Girardi V; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Filippi M; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Frohlich J; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Fink P; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Hansen AW; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil., Ferreira HL; Department of Veterinary Medicine, FZEA- USP, University of Sao Paulo, Pirassununga, São Paulo, Brazil., Afrough B; Health Security Agency, New Variant Assessment Platform (NVAP), UK., Kritz-Wilson A; Health Security Agency, New Variant Assessment Platform (NVAP), UK., Spilki FR; Departamento de Virologia, Laboratório de Microbiologia Molecular, Universidade Feevale, Novo Hamburgo, Rio Grande do Sul, Brazil.
Publikováno v:
Journal of medical virology [J Med Virol] 2024 Oct; Vol. 96 (10), pp. e29944.
Autor:
Jamal Z; National Institutes of Health, Islamabad, Pakistan., Haider SA; National Institutes of Health, Islamabad, Pakistan., Hakim R; National Institutes of Health, Islamabad, Pakistan., Humayun F; Jhpiego, Islamabad, Pakistan., Farooq MU; Jhpiego, Islamabad, Pakistan., Ammar M; National Institutes of Health, Islamabad, Pakistan., Afrough B; New Variant Assessment Platform, UK Health Security Agency, London, UK., Inamdar L; New Variant Assessment Platform, UK Health Security Agency, London, UK., Salman M; National Institutes of Health, Islamabad, Pakistan., Umair M; National Institutes of Health, Islamabad, Pakistan.
Publikováno v:
Journal of medical virology [J Med Virol] 2024 Jun; Vol. 96 (6), pp. e29727.
Autor:
Akande OW; Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland., Afrough B; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Amante M; Infectious Hazard Management, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Carter L; Department of Country Readiness Strengthening, World Health Organization Lyon Office, Lyon, France., Cunningham J; Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland., Hull NC; Global Health, Association of Public Health Laboratories, Bethesda, MD, United States., Inamdar L; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Jaguparov A; Infectious Hazard Management, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Marklewitz M; Genomics and Sequencing, FIND, Geneva, Switzerland., Musul B; Infectious Hazard Management, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Norberg A; Global Health, Association of Public Health Laboratories, Bethesda, MD, United States., Pereyaslov DI; Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland., Poates AL; Global Health, Association of Public Health Laboratories, Bethesda, MD, United States., Samaan G; Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland., Suresh A; Genomics and Sequencing, FIND, Geneva, Switzerland., Uplekar S; Genomics and Sequencing, FIND, Geneva, Switzerland., Wilhem A; New Variant Assessment Platform, UK Health Security Agency, London, United Kingdom., Salvi Le Garrec Zwetyenga J; Infectious Hazard Management, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Whistler T; Technical Advice and Partnership Department, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Publikováno v:
Frontiers in public health [Front Public Health] 2024 May 09; Vol. 12, pp. 1404243. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).
Autor:
D'Addiego J; UK Health Security Agency, Science Group, Porton Down, Salisbury, United Kingdom; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: jake.daddiego@ukhsa.gov.uk., Wand N; UK Health Security Agency, Science Group, Porton Down, Salisbury, United Kingdom., Afrough B; UK Health Security Agency, Science Group, Porton Down, Salisbury, United Kingdom., Fletcher T; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Kurosaki Y; National Research Centre for the Control and Prevention of Infectious Diseases, Nagasaki University, Japan., Leblebicioglu H; VM Medicalpark Samsun Hospital, Samsun, Türkiye., Hewson R; UK Health Security Agency, Science Group, Porton Down, Salisbury, United Kingdom; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; National Research Centre for the Control and Prevention of Infectious Diseases, Nagasaki University, Japan.
Publikováno v:
Journal of virological methods [J Virol Methods] 2024 Jan; Vol. 323, pp. 114833. Date of Electronic Publication: 2023 Oct 23.
Publikováno v:
Clinical & Experimental Immunology. May2019, Vol. 196 Issue 2, p157-166. 10p. 1 Diagram, 1 Chart.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mauldin MR; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McCollum AM; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Nakazawa YJ; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mandra A; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitehouse ER; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Davidson W; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Zhao H; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gao J; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Li Y; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Doty J; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Yinka-Ogunleye A; Nigerian Centre for Disease Control, Abuja, Nigeria., Akinpelu A; Nigerian Centre for Disease Control, Abuja, Nigeria., Aruna O; International Health Regulations Strengthening Project, Global Public Health, Public Health England, London, United Kingdom., Naidoo D; World Health Organization Country Office, Abuja, Nigeria., Lewandowski K; Public Health England, London, United Kingdom., Afrough B; Public Health England, London, United Kingdom., Graham V; Public Health England, London, United Kingdom., Aarons E; Public Health England, London, United Kingdom., Hewson R; Public Health England, London, United Kingdom., Vipond R; Public Health England, London, United Kingdom., Dunning J; Public Health England, London, United Kingdom., Chand M; Public Health England, London, United Kingdom., Brown C; Public Health England, London, United Kingdom., Cohen-Gihon I; Department of Biochemistry and Molecular Biology, Israel Institute for Biological Research, Ness-Ziona, Israel., Erez N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Shifman O; Department of Biochemistry and Molecular Biology, Israel Institute for Biological Research, Ness-Ziona, Israel., Israeli O; Department of Biochemistry and Molecular Biology, Israel Institute for Biological Research, Ness-Ziona, Israel., Sharon M; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Schwartz E; Institute of Tropical Medicine, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Faculty of Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Beth-Din A; Department of Biochemistry and Molecular Biology, Israel Institute for Biological Research, Ness-Ziona, Israel., Zvi A; Department of Biochemistry and Molecular Biology, Israel Institute for Biological Research, Ness-Ziona, Israel., Mak TM; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore., Ng YK; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore., Cui L; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore., Lin RTP; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore., Olson VA; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Brooks T; Public Health England, London, United Kingdom., Paran N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Ihekweazu C; Nigerian Centre for Disease Control, Abuja, Nigeria., Reynolds MG; Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Apr 19; Vol. 225 (8), pp. 1367-1376.
Autor:
Girt GC; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK.; Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK., Lakshminarayanan A; Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.; Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK., Huo J; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK.; Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.; Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK., Dormon J; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK., Norman C; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK., Afrough B; National Infection Service, Public Health England, Porton Down, Salisbury, UK., Harding A; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., James W; James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Owens RJ; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK.; Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.; Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK., Naismith JH; Structural Biology, The Rosalind Franklin Institute, Harwell Science and Innovation Campus, Didcot, UK.; Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.; Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK.
Publikováno v:
Royal Society open science [R Soc Open Sci] 2021 Sep 30; Vol. 8 (9), pp. 211016. Date of Electronic Publication: 2021 Sep 30 (Print Publication: 2021).
A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells.
Autor:
Funnell SGP; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK.; Quadram Institute Bioscience, Norwich Research Park, Norfolk, UK.; World Health Organization, Geneva, Switzerland., Afrough B; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK., Baczenas JJ; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA., Berry N; Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Control, London, UK., Bewley KR; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK., Bradford R; Biodefense and Emerging Infections Resources, NIH, Bethesda, MD, USA., Florence C; Office of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, NIAID, NIH, Bethesda, MD, USA., Duff YL; Division of Infectious Disease Diagnostics, National Institute for Biological Standards and Control, London, UK., Lewis M; Office of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, NIAID, NIH, Bethesda, MD, USA., Moriarty RV; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA., Connor SLO; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA., Osman KL; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK., Pullan S; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK., Rashid S; Biodefense and Emerging Infections Resources, NIH, Bethesda, MD, USA., Richards KS; PHE Porton Down, National Infection Service, Public Health England, Salisbury, Wiltshire, UK.; Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK., Stemple KJ; Office of Biodefense, Research Resources and Translational Research, Division of Microbiology and Infectious Diseases, NIAID, NIH, Bethesda, MD, USA., Knezevic I; World Health Organization, Geneva, Switzerland. knezevici@who.int.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Jun 17; Vol. 6 (1), pp. 83. Date of Electronic Publication: 2021 Jun 17.